Transactivated EGFR recruitment of ACTN4, therefore, is likely to be a common mechanism utilized by multiple CNS-infecting bacterial pathogens for BBB penetration, and these molecules are potential targets for future prevention and therapy of bacterial meningitis. This evidence concerns the gene ACTN4 and bacterial meningitis.